BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 705007)

  • 1. New microbial secondary metabolites under preclinical development for cancer treatment.
    Umezawa H
    Recent Results Cancer Res; 1978; 63():120-34. PubMed ID: 705007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecular microbial products enhancing immune response.
    Umezawa H
    Antibiot Chemother (1971); 1978; 24():9-18. PubMed ID: 655681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Secondary microbial metabolites with potentials for antineoplastic actions: antineoplastic antibiotics and immunopotentiators].
    Umezawa H
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1071-86. PubMed ID: 6191672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of new antineoplastic antibiotics based on newly discovered action mechanisms].
    Tanaka N
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1094-106. PubMed ID: 6191673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor antibiotics discovered and studied at the Institute of Microbial Chemistry.
    Takeuchi T
    J Cancer Res Clin Oncol; 1995; 121(9-10):505-10. PubMed ID: 7559728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Criteria for selection of new analogs of antitumor antibiotics.
    Goldin A
    Recent Results Cancer Res; 1978; 63():99-112. PubMed ID: 705018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial secondary metabolites with potential use in cancer treatment. (Plasmid involvement in biosynthesis and compounds.
    Umezawa H
    Biomedicine; 1977 Jul; 26(4):236-49. PubMed ID: 72569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part II - Small molecular weight immunomodulators produced by microorganisms.
    Umezawa H
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):19-23. PubMed ID: 7056602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of mitoxantrone against murine experimental tumors: comparative analysis against various antitumor antibiotics.
    Fujimoto S; Ogawa M
    Cancer Chemother Pharmacol; 1982; 8(2):157-62. PubMed ID: 7105379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Didemnin B. The first marine compound entering clinical trials as an antineoplastic agent.
    Chun HG; Davies B; Hoth D; Suffness M; Plowman J; Flora K; Grieshaber C; Leyland-Jones B
    Invest New Drugs; 1986; 4(3):279-84. PubMed ID: 3546184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and action of bleomycin.
    Umezawa H
    Prog Biochem Pharmacol; 1976; 11():18-27. PubMed ID: 63962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in antitumor antibiotics.
    Umezawa H
    Antibiot Chemother (1971); 1978; 23():76-87. PubMed ID: 77145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new antitumor antibiotic, kidamycin. II. Experimental treatment of cancer with kidamycin.
    Kanda N; Kono M; Asano K
    J Antibiot (Tokyo); 1972 Oct; 25(10):553-6. PubMed ID: 4648309
    [No Abstract]   [Full Text] [Related]  

  • 14. The quantitative structure-selectivity relationship of anthracycline antitumor activity and cardiac toxicity.
    Fink SI; Leo A; Yamakawa M; Hansch C; Quinn FR
    Farmaco Sci; 1980 Dec; 35(12):965-79. PubMed ID: 7202703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aclacinomycin A: a new antitumor antibiotic].
    Egorov LV; Ivanitskaia LP; Navashin SM
    Antibiotiki; 1982; 27(7):540-55. PubMed ID: 6753735
    [No Abstract]   [Full Text] [Related]  

  • 16. Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity.
    Hori S; Shirai M; Hirano S; Oki T; Inui T; Tsukagoshi S; Ishizuka M; Takeuchi T; Umezawa H
    Gan; 1977 Oct; 68(5):685-90. PubMed ID: 579346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tallysomycin, a new antitumor antibiotic complex related to bleomycin. III. Antitumor activity of tallysomycins A and B.
    Imanishi H; Ohbayashi M; Nishiyama Y; Kawaguchi H
    J Antibiot (Tokyo); 1978 Jul; 31(7):667-74. PubMed ID: 80402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
    Umezawa H
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):12-8. PubMed ID: 6173340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental evaluation of anthracycline analogs.
    Casazza AM
    Cancer Treat Rep; 1979 May; 63(5):835-44. PubMed ID: 455325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activities of (2"R)-4'-O-tetrahydropyranyl-adriamycin (THP) and its combination with other antitumor agents on murine tumors.
    Matsushita Y; Kumagai H; Yoshimoto A; Tone H; Ishikura T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1985 Oct; 38(10):1408-19. PubMed ID: 4066493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.